Stockreport

A Look At Summit Therapeutics (SMMT) Valuation After New Ivonescimab Phase III Data And FDA BLA Filing [Yahoo! Finance]

Summit Therapeutics Inc.  (SMMT) 
Last summit therapeutics inc. earnings: 6/12 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: summitplc.com/investors/investor-centre
PDF Summit Therapeutics (SMMT) drew fresh attention after presenting new Phase III ivonescimab data at the 2026 European Lung Cancer Congress, alongside an FDA Biologics Li [Read more]